Clinical Medicine Frontiers is an international, peer-reviewed open access journal dedicated to advancing research the field of clinical medicine. The journal provides a rapid publication process to ensure wide dissemination of high-quality articles to scientists, professionals, and interested individuals worldwide. Our goal is to serve as an efficient, reliable, and trusted platform for scholars and readers, publishing cutting-edge research in the field.
Abstract: Objective: To investigate the clinical efficacy of intravitreal Conbercept or Lucentis combined with Ex-Press drain implantation and panretina photocoagnlation in patient with neovascular glaucoma. Methods: A total of 60 patients (60 eyes) diagnosed with NVG from Jan. 2018 to Dec. 2020 were enrolled as the study subjects, who underwent glaucoma Ex-press drainage implantation and PRP, and intravitreal Conbercept or Lucentis 3 days before surgery. According to the random number lottery method, the patients were randomized into two groups, Conbercept group and Lucentis group, with 30 cases and 30 eyes in each group. The treatment effect for best corrected visual acuity (BCVA), intraocular pressure (IOP), status of neovascularization and complications incidence were compared between the two groups. Results: the IOP levels of patients in both groups were significantly reduced compared to those before surgery (P>0.05). At 7 days, 1 month and 3 months after treatment, IOP reduction and BCVA improvement in Conbercept group were better than those in Lucentis group (P<0.05). After 12 months of treatment, the overall success rate of the Conbercept group and the Lucentis group were 56.67% and 53.33%, respectively (P>0.05), and the complication rate was 26.67% and 36.67%, respectively (P>0.05). There was no difference in IOP reduction and BCVA improvement between the two groups at 6 and 12 months of treatment (P>0.05). Conclusion: The Clinical efficacy of intravitreal Conbercept or Lucentis combined with Ex-Press drain implantation and PRP in patient with neovascular glaucoma is definite. The short-term effect of IOP reduction and visual recovery in the Conbercept group is better than that in the Lucentis group.Abstract: Objective: To investigate the clinical efficacy of intravitreal Conbercept or Lucentis combined with Ex-Press drain implantation and panretina photocoagnlation in patient with neovascular glaucoma. Methods: A total of 60 patients (60 eyes) diagnosed with NVG from Jan. 2018 to Dec. 2020 were enrolled as the study subjects, who underwent glaucoma Ex-...Learn More
Abstract: Objective: To elaborate on the clinical strategy and application of emphasizing the concept of undigested treatment for non-alcoholic fatty liver disease. Method: By analyzing the relevant content in ancient and modern Mongolian medical literature such as "Four Parts of Ganlu", "Golden Chamber of Mongolian Medicine", "Internal Medicine of Mongolian Medicine", and combining my clinical experience summary and typical cases to confirm the clinical effect of differentiation and treatment of non-alcoholic fatty liver disease based on the concept of undigested Mongolian medicine. Result: The analysis of relevant literature records is generally consistent with clinical cases. In clinical practice, the premise is to regulate diet and daily life, and the dialectical treatment of non-alcoholic fatty liver disease is based on the principle of regulating stomach fire and aiding digestion. The therapeutic effect is obvious. Conclusion: The treatment of non-alcoholic fatty liver disease can improve the symptoms and indicators of non-alcoholic fatty liver disease by clearing the liver and tonifying the kidney based on indigestion, combined with constitution differentiation and treatment. It is worth further promoting and applying in the field of Mongolian medicine for treating liver disease. To further confirm the therapeutic effect of Mongolian medicine for non-alcoholic fatty liver disease, it is necessary to conduct extensive clinical prospective application research and related molecular mechanisms in the later stage Research in transcriptology, metabolomics, etc.Abstract: Objective: To elaborate on the clinical strategy and application of emphasizing the concept of undigested treatment for non-alcoholic fatty liver disease. Method: By analyzing the relevant content in ancient and modern Mongolian medical literature such as "Four Parts of Ganlu", "Golden Chamber of Mongolian Medicine", "Internal Medicine of Mongolian...Learn More
